Leishmaniasis chemotherapy—challenges and opportunities

Although there have been significant advances in the treatment of visceral leishmaniasis (VL), there remain challenges to ensure that treatments effective in India are also effective in other regions of the world and to identify treatment for post kala-azar dermal leishmaniasis as well as the opport...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical microbiology and infection 2011-10, Vol.17 (10), p.1478-1483
Hauptverfasser:	Croft, S.L., Olliaro, P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-HIV Agents - administration & dosage Anti-HIV Agents - therapeutic use Antiprotozoal Agents - administration & dosage Antiprotozoal Agents - therapeutic use Clinical Trials as Topic - standards Coinfection - drug therapy Coinfection - parasitology Coinfection - virology Cutaneous leishmaniasis Drug Discovery drug sensitivity HIV - pathogenicity HIV co-infection HIV Infections - drug therapy HIV Infections - parasitology HIV Infections - virology Human immunodeficiency virus Humans India - epidemiology Leishmania - pathogenicity Leishmaniasis, Cutaneous - drug therapy Leishmaniasis, Cutaneous - epidemiology Leishmaniasis, Cutaneous - parasitology Leishmaniasis, Visceral - drug therapy Leishmaniasis, Visceral - epidemiology Leishmaniasis, Visceral - parasitology Parasitic diseases Paromomycin - administration & dosage Paromomycin - therapeutic use R&D Research & development Research - organization & administration standardization visceral leishmaniasis
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!